May 30, 2025 • The Trump administration has thrown so many curveballs at colleges and universities, it can be hard to keep track. But there's logic behind the many efforts, from cutting research ...

Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...

African countries have made progress in expanding their genomics and bioinformatics workforces for public health, yet several barriers pose risks to workforce retention and long-term sustainability.